CALC
CalciMedica, Inc. Common Stock
NASDAQ: CALC · HEALTHCARE · BIOTECHNOLOGY
$0.62
+3.47% today
Updated 2026-05-06
Market cap
$9.22M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.98
Dividend yield
—
52W range
$0 – $7
Volume
0.3M
CalciMedica, Inc. Common Stock (CALC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-28.22M | $-31.21M | $-32.06M | $-31.50M | $-11.76M | $-25.73M | $-21.15M | $-21.18M |
| Capital expenditures | $1.46M | $605000.00 | $1.02M | $488000.00 | $4000.00 | $78000.00 | $8000.00 | $28000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $348000.00 | $738000.00 | $1.79M | $5.38M | $1.81M | $12.04M | $2.31M | $2.97M |
| Free cash flow | $-29.68M | $-31.82M | $-33.09M | $-31.99M | $-11.76M | $-25.81M | $-21.15M | $-21.21M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |